ÌÇÐÄvlog´«Ã½

Syringe Pump Market Analysis

The syringe pumps market is expected to grow at a CAGR of 7.0% over the forecast period, 2022-2027.

The impact of COVID-19 on the market studied was substantial. The pandemic resulted in the occupying several ICUs and emergency wards with COVID-19 patients, resulting in the postponement of surgeries. This has greatly affected the adoption of syringe pumps within the patient population, ultimately hampering the market's growth. For instance, in April 2022, Nova Scotia's QEII Health Sciences Centre decided to postpone most non-urgent and elective surgeries due to an increasing number and acuity of patients with COVID-19 in the hospital. Furthermore, according to the article titled "The Impact of COVID-19 pandemic on Waiting Times for elective surgery patients: A multicenter study", published in July 2021 in PLOS ONE journal, stated that elective surgical waiting times have grown by up to one-third as a result of the pandemic's healthcare restructurings.

Additionally, as per an article titled "Did COVID-19 delays in surgical management lead to patient morbidity in the orthopedic oncological population?", published in April 2021 in the National Library of Medicine, cancer surgeries globally were fragile during the whole lockdown, and morbidity in patients increased due to delayed or canceled surgeries during COVID-19. The study further stated that the most common morbidity (52 percent) was persistent pain or disability, and the second most common morbidity (40 percent) was a delay in diagnosis. As syringe pumps are widely used in patients with cancer treatments, the uptake of the products witnessed a significant decline throughout the pandemic phase. However, considering the resumption of surgeries and procedures worldwide, the market is anticipated to gain traction in the near future. For instance, in April 2022, the Victorian government announced a USD 1.5 billion package to assist in clearing the queue of elective surgery procedures that have been postponed due to COVID-19. Such instances are likely to have a positive impact on the usage of syringe pumps among the patient population, thereby driving the market's growth.

Furthermore, factors driving the growth of the market include an increase in the prevalence of chronic diseases such as cardiovascular and respiratory diseases, which leads to the increased use of syringe pumps for surgical treatment. In several hospital settings, automated pumps have been employed for the effective infusion of medications inside the patient's body. Syringe pumps are becoming more popular as healthcare facilities become more automated and surgical procedures become less intrusive. Cancer, diabetes, and gastroenterology are some of the diseases in which syringe pumps are mostly used. As per the research study published by the American Cancer Society in February 2021, titled "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries", cancer has a high prevalence globally and 19.3 million new cases are reported each year, of which nearly 10 million deaths take place each year due to cancer. Female breast cancer is the most commonly diagnosed cancer in women, with 2.3 million new cases every year, followed by lung cancer. The global burden of cancer is estimated to have a 47% rise by 2040 compared to 2020, reaching 28.4 million cases. Approximately 60% of these cancer patients require chemotherapy, which is mostly administered using infusion pumps.

Similarly, the demand for syringe pumps is expected to increase owing to a surge in the incidences of chronic disease cases, such as dental, urology, gynecology, ophthalmology, neurology, orthopedics, and cardiovascular diseases, as well as an increase in demand for effective treatment processes. For instance, according to a study titled "Heart Disease" published by the Center for Disease Control and Prevention in February 2022, coronary heart disease affects 18.2 million people in the United States. Heart attack is the second major cause of cardio disease and affects 805,000 people in the United States each year.

However, several incidences of medication errors associated with syringe pumps are major concerns for hospitals, which act as a restraining factor for future market growth.

Syringe Pump Market Trends

This section covers the major market trends shaping the Syringe Pump Market according to our research experts:

The Infusion Pumps Segment is Anticipated to Hold the Largest Market Share throughout the Forecast Years.

Syringe Pump Industry Segmentation

As per the scope of the report, syringe pumps are used to infuse fluid with medication or without medication in some circumstances. The syringe Pumps Market is segmented by Type (Infusion Pumps and Withdrawal Pumps), By End-User (Hospitals, Clinics, and Ambulatory Care Settings), Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America).